
|Articles|January 1, 2007
Will prostate cancer respond to metabolic-directed treatment?
Chicago-Findings from systematic research being conducted by researchers at the University of California, Davis suggest that arginine deprivation may be a novel treatment in some prostate cancers.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
2
Nicole L. Miller, MD, FACS, on assessing patients after BPH treatment failure
3
Study suggests potential diuretic effect with nadofaragene firadenovec
4
RAD-IO: Durvalumab plus chemoradiotherapy is feasible in MIBC
5











